Crossmark

Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12936-015-0946-2

Published Online: 2015-10-29

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hawkes, Michael T.

Conroy, Andrea L.

Opoka, Robert O.

Hermann, Laura

Thorpe, Kevin E.

McDonald, Chloe

Kim, Hani

Higgins, Sarah

Namasopo, Sophie

John, Chandy

Miller, Chris

Liles, W. Conrad

Kain, Kevin C.
Funding

Funding for this research was provided by:

Institute of Infection and Immunity (CA) (Clinician-Scientist Training Award, MOP-244701, MOP-13721, MOP-136813, Post-Doctoral Research Award)

Sandra Rotman Centre for Global Health

Canada Research Chair in Molecular Parasitology

Canada Research Chair in Infectious Diseases and Inflammation

Kim Kertland

Tesari Foundation

Rotary International (K-W group)